SCHEMBL29637710

SCHEMBL29637710

CCNC(=O)CCCCCCCCCCCC(N)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.72
GAA P10253 1/20 0.47
SOAT1 P35610 2/20 0.45
MEN1 O00255 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
EPHX2 P34913 1/20 0.45
HSP90AA1 P07900 1/20 0.45
DNM1 Q05193 2/20 0.44
RECQL P46063 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
CASP2 P42575 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29622817 1.00 FAAH (0.72) FAAHGAASOAT1MEN1TP53
SCHEMBL29637719 1.00 FAAH (0.72) FAAHGAASOAT1MEN1TP53
SCHEMBL6683810 1.00 FAAH (0.72) FAAHGAASOAT1MEN1TP53
SCHEMBL4758347 0.98 FAAH (0.68) FAAHGAASOAT1MEN1TP53
Octadecanoic Acid Amide SCHEMBL29144433 0.94 FAAH (0.84) FAAHSOAT1MEN1TP53CYP1A2
Palmitamide SCHEMBL28248066 0.94 FAAH (0.84) FAAHSOAT1MEN1TP53CYP1A2
SCHEMBL6679258 0.93 FAAH (0.61) FAAHGAASOAT1MEN1TP53
SCHEMBL14500856 0.92 FAAH (0.62) FAAHMEN1KMT2AEPHX2DNM1
Propionic Acid SCHEMBL28737137 0.92 FAAH (0.62) FAAHGAAMEN1KMT2AEPHX2
Propionic Acid SCHEMBL28737145 0.92 FAAH (0.62) FAAHGAAMEN1KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089408-A1 TETRAHYDRONAPHTHALENE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广州市恒诺康医药科技有限公司 2022-05-05 WO disclosed